Author: zakaria
-
Global Fund replenishment: the Gulf Cooperation Council (GCC) must announce its pledge before the next Board Meeting
Statement from 46 Organizations Wednesday, December 3rd, 2025 As the world faces unprecedented health challenges, the Middle East and North Africa (MENA) region is entering a critical phase marked by an accelerating health crisis. The region is experiencing the fastest-growing HIV epidemic globally, alongside a rising burden of tuberculosis and fragile health systems in several…
-
Data Exclusivity: How Moroccan Law Risks Making Ozempic a Medicine for the Rich
Press Release – ITPC-MENA The Moroccan Agency for Medicines and Health Products (AMMPS) has just authorized the marketing of Ozempic®, an injectable semaglutide-based medication indicated for the treatment of type 2 diabetes. Administered once a week, this treatment is presented as a significant therapeutic advance for people living with diabetes, a chronic disease that is…
-
Terms of Reference for the Recruitment of a Consultant for Policy Brief Development
Position Title: Consultant for Policy Brief Development on the Global Fund’s Impact in the MENA Region for GC8 Organization(s): ITPC-MENA and MENA H Coalition Duration of Consultancy: 5 effective working days Background : The Middle East and North Africa (MENA) region is experiencing a growing HIV epidemic, characterized by specific challenges in data availability and policy…
-
A Powerful Tribute to Professor Hakima Himmich: A Life of Courage, Justice, and Resistance
🗓️ On May 13, 2025, during the 3rd Global Summit on Intellectual Property and Access to Medicines (GSIPA2M2025) held in Marrakech and co-organized by ITPC-MENA, a deeply emotional moment captured the audience. A powerful tribute was paid to Professor Hakima Himmich, a true icon in the fight for health and social justice – in Morocco, across the MENA region, and far…
-
HIV PREVENTION & ACCOUNTABILITY: A MULTI-COUNTRY COMMUNITY PERSPECTIVE 2025
This report provides a civil society analysis of the HIV prevention response, outlining the progress and gaps in five countries: Egypt, Jordan, Lebanon, Morocco, and Tunisia. The findings inform a set of key recommendations aimed at addressing these urgent challenges and strengthening the response in MENA. DOWNLOAD PDF تنزيل ملف PDF TÉLÉCHARGER PDF Frontline AIDS…
-
Call for Consultant: Acceptance Study of New Generation Long-Acting ARVs Among PLWHIV in the MENA Region
Terms of Reference (ToR) for ConsultationDemand Creation for New Generation ARVs – Acceptance Study Among PLWHIV 1. Context and Justification The Middle East and North Africa (MENA) region faces a growing HIV epidemic, characterized by increasing uncertainties regarding its incidence and consequences. Data indicate that AIDS-related deaths surged by 66% between 2005 and 2013, emphasizing…
-
The MENA H Coalition calls for sustained investments in the fight against tuberculosis in the MENA region
Joint press release FOR IMMEDIATE RELEASE MENA-H coalition urges urgent action to combat tuberculosis in the region, with emphasis on innovation and universal health coverage 2025, March 24 – On World Tuberculosis Day, the MENA-H Coalition issues an urgent call to intensify efforts to eliminate tuberculosis (TB) in the Middle East and North Africa (MENA)…
-
Results of a study on lenacapavir and two broadly neutralizing antibodies were presented at CROI 2025.
At the Conference on Retroviruses and Opportunistic Infections (CROI 2025) in San Francisco, results were presented from a Phase II study examining the efficacy of a combination of lenacapavir (TN Sunlenca) and two broadly neutralizing antibodies (bNAbs) – teropavimab and zinlirvimab. The study results indicate that this regimen could form the basis of a complete…
-
Call for Talents: Transform the Fight against HIV with ADP-MENA (Activists Development Program in MENA Region)
Context: The Middle East and North Africa (MENA) region continues to face major public health challenges related to HIV/AIDS. Key populations, including young people, men who have sex with men, sex workers, and injecting drug users, face significant barriers to accessing prevention and treatment services. These obstacles are exacerbated by stigma, discrimination, and a lack…
-
In Argentina, Gilead’s patent applications for lenacapavir have been rejected
The National Institute of Industrial Property of Argentina (INPI) has rejected patent applications from Gilead for the drug lenacapavir – an innovative long-acting injectable drug that has proven effective as an option for PrEP and the treatment of HIV with multi-drug resistance. Previously, the Argentine organization FGEP (Foundation for the Study and Research of Patent…